Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

QLT and Ciba Vision seek expanded labeling for Visudyne

Aug. 18, 2000

Bausch & Lomb and Muro to copromote Optivar

Aug. 16, 2000

Retinoid supplementation improves mouse model of childhood blindness

Aug. 11, 2000

FDA approves Rescula for treatment of glaucoma

Aug. 7, 2000

Visudyne approved in E.U. for treatment of wet AMD

Aug. 1, 2000

Tetracyclines as a valuable and relatively safe therapy for corneal ulceration

July 31, 2000

Topically applied GAG synthesis inhibitors useful for corneal haze

July 27, 2000

Nucleotides in development at Inspire for various clinical indications

July 20, 2000

Alcon claims use of AIT-082 and other neurotrophic factor enhancers in ophthalmic disorders

July 5, 2000

New market launch for Azopt

June 30, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...